Organised cancer screening among women who receive medically assisted reproduction treatments
Walker, A. R.; Odahl, S.; Venetis, C.; Jorm, L.; Hacker, N. F.; Chapman, M.; Anazodo, A. C.; Norman, R. J.; Stern, C.; Sansom-Daly, U. M.; Chambers, G. M.; Vajdic, C. M.
Show abstract
There are no published data on cancer screening by women using medically assisted reproduction (MAR). Such data would aid interpretation of the cancer incidence and risk profiles for this group. Using linked population-based Australian health registries and administrative datasets, we compared organised publicly funded cervical and breast screening episodes for women who received one of three types of MAR and matched women who did not between 1991 and 2016. We modelled the proportion of women screened in the three years before and after first MAR treatment, adjusting for age, remoteness, parity, socio-economic disadvantage, cancer history, and uptake of the other screening program. After adjustment, a greater proportion of women who received MAR than women who did not had cervical screening before MAR (77.3%-84.1% vs 57.5%-62.0%, depending on treatment) and after MAR (77.0%-78.5% vs 68.1%-68.3%). Contrastingly, breast screening estimates were 7.6%-9.6% vs 9.3%-10.5% before MAR and 11.0%-15.0% vs 12.8%-14.9% after MAR.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.